Why this grouping
MONDO alignment & provenance
closeMatch: the grouping corresponds to the MONDO Charcot-Marie-Tooth disease class, but is implemented as an explicit curated subset of current dismech Disease entries rather than as an automatic MONDO subtree closure.
MONDO consistency: consistent Listed members are the current KB Charcot-Marie-Tooth Disease, Charcot-Marie-Tooth Disease Type 1, and Charcot-Marie-Tooth Disease Type 2 umbrella entries, plus the two gene-anchored standalone subtype entries curated so far (CMT2W/HARS1 and CMT2JJ/BAG3). Additional CMT subtypes should be added only when standalone Disease entries are curated; subtypes carried inside another entry's `has_subtypes` list are deliberately not listed here.
Membership criteria
- OR
- HAS PHENOTYPE
Distal muscle weakness HP:0002460
Distal muscle weakness.
- HAS PHENOTYPE
Distal sensory impairment HP:0002936
Distal sensory impairment.
- HAS PHENOTYPE
Pes cavus HP:0001761
Pes cavus.
- HAS PHENOTYPE
Hyporeflexia HP:0001265
Hyporeflexia.
- HAS PHENOTYPE
Areflexia HP:0001284
Areflexia.
- HAS PHENOTYPE
Distal muscle weakness HP:0002460
Coverage and gaps
No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Distal muscle weakness. HP:0002460 | C1.2 Distal sensory impairment. HP:0002936 | C1.3 Pes cavus. HP:0001761 | C1.4 Hyporeflexia. HP:0001265 | C1.5 Areflexia. HP:0001284 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| listed with MONDO ID |
Autosomal dominant Charcot-Marie-Tooth disease type 2W
DISEASE
Differentiating mechanismAxonal CMT caused by heterozygous variants in the catalytic domain of HARS1, the cytoplasmic histidyl-tRNA synthetase. Distinguished within CMT2 by a translation-machinery lesion rather than a myelin, transport or metabolic one, and by allele-specific biochemistry: some alleles mistranslate histidine while others reduce enzyme abundance, which splits them into histidine-rescued and histidine-harmed groups. Shares the aminoacyl-tRNA synthetase mechanism class with the GARS1 arm curated inside Charcot-Marie-Tooth Disease Type 2.
HARS1 hgnc:4816
|
Autosomal dominant Charcot-Marie-Tooth disease type 2W
MONDO:0014711
|
yes | yes | not assessed | listed | satisfied | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Charcot-Marie-Tooth Disease
DISEASE
Differentiating mechanismBroad genetically heterogeneous CMT umbrella entry spanning demyelinating, axonal, intermediate, recessive, and X-linked inherited motor-sensory neuropathies that converge on distal peripheral nerve dysfunction with length-dependent weakness, sensory loss, pes cavus, and reduced reflexes.
|
Charcot-Marie-Tooth disease
MONDO:0015626
|
yes | yes | not assessed | listed | satisfied | SATISFIED | SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Charcot-Marie-Tooth Disease Type 2
DISEASE
Differentiating mechanismAxonal CMT with primary motor and sensory axon degeneration, including MFN2-related mitochondrial fusion and transport failure, NEFL neurofilament disruption, RAB7A endolysosomal trafficking defects, GARS1 tRNA-synthetase-mediated axonal toxicity, and SORD sorbitol-pathway disease.
MFN2 hgnc:16877
SORD-related recessive axonal CMT2 links sorbitol dehydrogenase loss to peripheral nerve metabolic stress and is mechanistically distinct from dominant MFN2, NEFL, RAB7A, and GARS1 forms while sharing the axonal CMT2 phenotype.
SORD hgnc:11184
|
Charcot-Marie-Tooth disease type 2
MONDO:0018993
|
yes | yes | not assessed | listed | satisfied | SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | SATISFIED |
| listed with MONDO ID |
Charcot-Marie-Tooth disease, axonal, type 2JJ
DISEASE
Differentiating mechanismAdult-onset axonal CMT caused by heterozygous BAG3 variants at the second conserved IPV motif, understood as a toxic gain of function that relocates chaperone-assisted selective autophagy components into insoluble aggresomes — shown in vitro for the Pro209 mutant class including the recurrent CMT2JJ allele p.Pro209Ser, though what makes Ser neuropathic and Leu myopathic is unexplained. Mechanistically a proteostasis disease rather than a myelin, transport or tRNA-charging defect; the nearest arm on that axis is CMT2F, curated inside Charcot-Marie-Tooth Disease Type 2, whose HSPB1/HSP27 lesion is also a small heat-shock protein (HSPB8 is BAG3's direct CASA partner) though that entry frames it through neurofilament and axonal-transport disruption. Separated from BAG3 myofibrillar myopathy 6 by the substitution at codon 209 — Ser is the recurrent neuropathy allele and Leu the childhood myopathy allele — but the partition is not clean: a p.Pro209Leu patient has been reported with a CMT-like axonal polyneuropathy and no cardiomyopathy, so the two alleles may produce overlapping spectra with different centres of gravity rather than separate diseases.
BAG3 hgnc:939
|
Charcot-Marie-Tooth disease, axonal, type 2JJ
MONDO:0976227
|
yes | yes | not assessed | listed | satisfied | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Charcot-Marie-Tooth Disease Type 1
DISEASE
Differentiating mechanismDemyelinating CMT dominated by Schwann-cell and peripheral myelin pathology, commonly involving PMP22 dosage gain in CMT1A, MPZ myelin protein defects, GJB1 connexin-32 dysfunction in overlapping X-linked or intermediate CMT, and EGR2 transcriptional regulation defects.
PMP22 hgnc:9118
MPZ-related CMT1 disrupts myelin protein zero structure, trafficking, or unfolded-protein responses in Schwann cells, producing demyelinating peripheral neuropathy with slowed conduction and onion-bulb pathology.
MPZ hgnc:7225
|
Demyelinating Charcot-Marie-Tooth disease (CMT1)
MONDO:0019011
|
yes | yes | not assessed | listed | satisfied | SATISFIED | SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED |
Source
View YAML on GitHubRaw YAML
name: Charcot-Marie-Tooth Diseases
display_name: Charcot-Marie-Tooth Diseases
creation_date: "2026-06-14T00:00:00Z"
description: >-
A curated grouping of explicit Charcot-Marie-Tooth disease entries spanning
the broad CMT umbrella entry, the currently curated type 1 demyelinating and
type 2 axonal CMT entries, and the gene-anchored standalone subtype entries
curated so far (CMT2W/HARS1 and CMT2JJ/BAG3). Members share inherited
length-dependent
peripheral neuropathy with distal muscle weakness, distal sensory impairment,
pes cavus, reduced reflexes, gait impairment, and progressive motor-sensory
axon or Schwann-cell/myelin pathology.
grouping_basis:
- SHARED_MECHANISM
- SHARED_PHENOTYPE
grouping_rationale: >-
Grouped as an explicit curated union of Disease entries named as
Charcot-Marie-Tooth disease or major CMT type-level entries, not as all
hereditary peripheral neuropathies. The shared boundary is inherited
motor-sensory peripheral neuropathy with convergent distal axon degeneration
and/or Schwann-cell demyelination. Current members are the umbrella CMT entry,
the curated type 1 and type 2 entries, and the gene-anchored standalone
subtype entries CMT2W (HARS1) and CMT2JJ (BAG3). Boundary entities such as
hereditary neuropathy with liability to pressure palsies and PRPS1 deficiency
spectrum are not included unless a standalone entry is explicitly curated as
a CMT disease subtype.
mappings:
mondo_mappings:
- term:
id: MONDO:0015626
label: Charcot-Marie-Tooth disease
mapping_predicate: skos:closeMatch
mapping_source: MONDO
mapping_justification: >-
closeMatch: the grouping corresponds to the MONDO Charcot-Marie-Tooth
disease class, but is implemented as an explicit curated subset of current
dismech Disease entries rather than as an automatic MONDO subtree closure.
consistency:
- reference: MONDO
consistent: CONSISTENT
notes: >-
Listed members are the current KB Charcot-Marie-Tooth Disease,
Charcot-Marie-Tooth Disease Type 1, and Charcot-Marie-Tooth Disease
Type 2 umbrella entries, plus the two gene-anchored standalone subtype
entries curated so far (CMT2W/HARS1 and CMT2JJ/BAG3). Additional CMT
subtypes should be added only when standalone Disease entries are
curated; subtypes carried inside another entry's `has_subtypes` list are
deliberately not listed here.
membership_criteria:
- description: >-
A member is an explicit Charcot-Marie-Tooth disease entry with inherited
peripheral motor-sensory neuropathy and at least one characteristic shared
CMT manifestation such as distal muscle weakness, distal sensory impairment,
pes cavus, hyporeflexia, or areflexia.
criteria_semantics: NECESSARY
logic:
operator: OR
operands:
- criterion_predicate: HAS_PHENOTYPE
description: Distal muscle weakness.
phenotype_term:
preferred_term: Distal muscle weakness
term:
id: HP:0002460
label: Distal muscle weakness
- criterion_predicate: HAS_PHENOTYPE
description: Distal sensory impairment.
phenotype_term:
preferred_term: Distal sensory impairment
term:
id: HP:0002936
label: Distal sensory impairment
- criterion_predicate: HAS_PHENOTYPE
description: Pes cavus.
phenotype_term:
preferred_term: Pes cavus
term:
id: HP:0001761
label: Pes cavus
- criterion_predicate: HAS_PHENOTYPE
description: Hyporeflexia.
phenotype_term:
preferred_term: Hyporeflexia
term:
id: HP:0001265
label: Hyporeflexia
- criterion_predicate: HAS_PHENOTYPE
description: Areflexia.
phenotype_term:
preferred_term: Areflexia
term:
id: HP:0001284
label: Areflexia
members:
- member: Charcot-Marie-Tooth Disease
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Broad genetically heterogeneous CMT umbrella entry spanning demyelinating,
axonal, intermediate, recessive, and X-linked inherited motor-sensory
neuropathies that converge on distal peripheral nerve dysfunction with
length-dependent weakness, sensory loss, pes cavus, and reduced reflexes.
- member: Charcot-Marie-Tooth Disease Type 1
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Demyelinating CMT dominated by Schwann-cell and peripheral myelin
pathology, commonly involving PMP22 dosage gain in CMT1A, MPZ myelin
protein defects, GJB1 connexin-32 dysfunction in overlapping X-linked or
intermediate CMT, and EGR2 transcriptional regulation defects.
gene:
preferred_term: PMP22
term:
id: hgnc:9118
label: PMP22
- description: >-
MPZ-related CMT1 disrupts myelin protein zero structure, trafficking, or
unfolded-protein responses in Schwann cells, producing demyelinating
peripheral neuropathy with slowed conduction and onion-bulb pathology.
gene:
preferred_term: MPZ
term:
id: hgnc:7225
label: MPZ
- member: Charcot-Marie-Tooth Disease Type 2
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Axonal CMT with primary motor and sensory axon degeneration, including
MFN2-related mitochondrial fusion and transport failure, NEFL
neurofilament disruption, RAB7A endolysosomal trafficking defects, GARS1
tRNA-synthetase-mediated axonal toxicity, and SORD sorbitol-pathway
disease.
gene:
preferred_term: MFN2
term:
id: hgnc:16877
label: MFN2
- description: >-
SORD-related recessive axonal CMT2 links sorbitol dehydrogenase loss to
peripheral nerve metabolic stress and is mechanistically distinct from
dominant MFN2, NEFL, RAB7A, and GARS1 forms while sharing the axonal CMT2
phenotype.
gene:
preferred_term: SORD
term:
id: hgnc:11184
label: SORD
- member: Autosomal dominant Charcot-Marie-Tooth disease type 2W
member_type: DISEASE
display_name: CMT2W (HARS1)
differentiating_mechanisms:
- description: >-
Axonal CMT caused by heterozygous variants in the catalytic domain of
HARS1, the cytoplasmic histidyl-tRNA synthetase. Distinguished within CMT2
by a translation-machinery lesion rather than a myelin, transport or
metabolic one, and by allele-specific biochemistry: some alleles
mistranslate histidine while others reduce enzyme abundance, which splits
them into histidine-rescued and histidine-harmed groups. Shares the
aminoacyl-tRNA synthetase mechanism class with the GARS1 arm curated inside
Charcot-Marie-Tooth Disease Type 2.
gene:
preferred_term: HARS1
term:
id: hgnc:4816
label: HARS1
- member: Charcot-Marie-Tooth disease, axonal, type 2JJ
member_type: DISEASE
display_name: CMT2JJ (BAG3)
differentiating_mechanisms:
- description: >-
Adult-onset axonal CMT caused by heterozygous BAG3 variants at the second
conserved IPV motif, understood as a toxic gain of function that relocates
chaperone-assisted selective autophagy components into insoluble
aggresomes — shown in vitro for the Pro209 mutant class including the
recurrent CMT2JJ allele p.Pro209Ser, though what makes Ser neuropathic and
Leu myopathic is unexplained. Mechanistically a proteostasis disease rather
than a myelin, transport or tRNA-charging defect; the nearest arm on that
axis is CMT2F, curated inside Charcot-Marie-Tooth Disease Type 2, whose
HSPB1/HSP27 lesion is also a small heat-shock protein (HSPB8 is BAG3's
direct CASA partner) though that entry frames it through neurofilament and
axonal-transport disruption. Separated from BAG3 myofibrillar myopathy 6
by the substitution at codon 209 — Ser is the recurrent neuropathy allele
and Leu the childhood myopathy allele — but the partition is not clean: a
p.Pro209Leu patient has been reported with a CMT-like axonal polyneuropathy
and no cardiomyopathy, so the two alleles may produce overlapping spectra
with different centres of gravity rather than separate diseases.
gene:
preferred_term: BAG3
term:
id: hgnc:939
label: BAG3
notes: >-
Exclude hereditary neuropathy with liability to pressure palsies, isolated
distal hereditary motor neuropathy, hereditary sensory and autonomic
neuropathy, PRPS1 Deficiency Spectrum, mitochondrial trifunctional protein
deficiency, and broad peripheral neuropathy entries unless a standalone
Disease entry is explicitly curated as a Charcot-Marie-Tooth disease subtype.